DEVELOPMENT OF NOVEL PRECLINICAL MODELS OF SECONDARY RESISTANCE TO THE PI3KΔ INHIBITOR IDELALISIB IN SPLENIC MARGINAL ZONE LYMPHOMA (SMZL)
Arribas, A.J., Gaudio, E., Rinaldi, A., Cascione, L., Tarantelli, C., Kwee, I., Stathis, A., Zucca, E., Rossi, D., Bertoni, F.Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2438_119
Date:
June, 2017
File:
PDF, 68 KB
english, 2017